[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 915 Agreed to Senate (ATS)]
<DOC>
118th CONGRESS
2d Session
S. RES. 915
Designating September 2024 as ``National Prostate Cancer Awareness
Month''.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
November 21, 2024
Mr. Crapo (for himself, Mr. Booker, Mr. Risch, Mr. Van Hollen, Mrs.
Capito, Mr. Helmy, and Mr. Cardin) submitted the following resolution;
which was considered and agreed to
_______________________________________________________________________
RESOLUTION
Designating September 2024 as ``National Prostate Cancer Awareness
Month''.
Whereas, as of September 2024, more than 3,300,000 prostate cancer survivors are
living in the United States;
Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer
in their lifetimes and 1 in 44 men in the United States will die from
prostate cancer;
Whereas prostate cancer is the most commonly diagnosed non-skin cancer and the
second-leading cause of cancer-related deaths among men in the United
States;
Whereas the American Cancer Society estimates that, in 2024, 299,010 men will be
diagnosed with, and more than 35,250 men will die of, prostate cancer;
Whereas 40 percent of newly diagnosed prostate cancer cases occur in men under
the age of 65;
Whereas the odds of developing prostate cancer rise rapidly after age 50;
Whereas having a father or brother with prostate cancer more than doubles the
risk of a man developing prostate cancer, with a higher risk for men who
have a brother with the disease and the highest risk for men with
several affected relatives;
Whereas screening by a digital rectal examination and a prostate-specific
antigen blood test can detect the disease at the earlier, more treatable
stages, which could increase the chances of survival for more than 5
years to nearly 100 percent;
Whereas only 34 percent of men survive more than 5 years if diagnosed with
prostate cancer after the cancer has metastasized;
Whereas there are typically no noticeable symptoms of prostate cancer in the
early stages, making appropriate screening critical;
Whereas, in fiscal year 2024, Congress appropriated $48,581,000,000 to the
National Institutes of Health, including $7,220,000,000 for the National
Cancer Institute;
Whereas, in fiscal year 2024, Congress appropriated $110,000,000 for the
Prostate Cancer Research Program of the Department of Defense;
Whereas the Department of Veterans Affairs has established 21 Precision Oncology
Centers of Excellence in order to deliver precision oncology services to
veterans suffering from prostate cancer;
Whereas ongoing research promises further improvements in prostate cancer
prevention, early detection, and treatment; and
Whereas educating people in the United States, including health care providers,
about prostate cancer and early detection strategies is crucial to
saving the lives of men and preserving and protecting families: Now,
therefore, be it
Resolved, That the Senate--
(1) designates September 2024 as ``National Prostate Cancer
Awareness Month'';
(2) declares that steps should be taken--
(A) to raise awareness about the importance of
screening methods for, and treatment of, prostate
cancer;
(B) to encourage research--
(i) to improve screening and treatment for
prostate cancer;
(ii) to discover the causes of prostate
cancer; and
(iii) to develop a cure for prostate
cancer; and
(C) to continue to consider ways to improve access
to, and the quality of, health care services for
detecting and treating prostate cancer; and
(3) calls on the people of the United States, interest
groups, and affected persons--
(A) to promote awareness of prostate cancer;
(B) to take an active role in the fight to end the
devastating effects of prostate cancer on individuals,
families, and the economy; and
(C) to observe National Prostate Cancer Awareness
Month with appropriate ceremonies and activities.
<all>